Last reviewed · How we verify

NCT05962905: INCATH

Accuracy Performance Verification of the INVOS™ System in Pediatrics

Completed Last updated 9 May 2025
What this trial tests

trial testing Blood sample in Cerebral Oxygenation in 110 participants. Completed in 30 April 2025.

Timeline
16 November 2023
Primary endpoint
30 November 2024
30 April 2025

Quick facts

Lead sponsorMedtronic - MITG
StatusCompleted
Study typeOBSERVATIONAL
Enrollment110
Start date16 November 2023
Primary completion30 November 2024
Estimated completion30 April 2025
Sites5 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medtronic - MITG — full company profile →

Who can join

Adults 0 to 21, any sex, with Cerebral Oxygenation or Pediatric ALL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, observational, multi-center trial designed to capture calibration and performance evaluation data with the INVOS™ system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood sample

Trials testing the same drug.

Other recruiting trials for Cerebral Oxygenation

Currently open trials in the same condition.

Other Medtronic - MITG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05962905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing